Changing the Subcellular Location of the Oncoprotein Bcr-Abl Using Rationally Designed Capture Motifs

Author： Dixon Andrew   Constance Jonathan   Tanaka Tomoyuki   Rabbitts Terence   Lim Carol  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.29, Iss.4, 2012-04, pp. : 1098-1109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BCR-ABL as a target for novel therapeutic interventions

By Kindler T   Meyer RG   Fischer T  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 1, 2002-02 ,pp. : 85-101

Informa Healthcare

Access to resources Recommend Favorite

Structural biology in the battle against BCR-Abl

By Nagar Bhushan  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 9, 2008-09 ,pp. : 975-988

Informa Healthcare

Access to resources Recommend Favorite

Effects of BCR-ABL Inhibitors on Anti-Tumor Immunity

By  

Current Medicinal Chemistry, Vol. 18, Iss. 34, 2011-12 ,pp. : 5174-5184

Bentham Science Publishers

Access to resources Recommend Favorite

Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib?

By Doggrell Sheila A   Christensen Anne-Marie  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 1, 2011-01 ,pp. : 157-163

Informa Healthcare

Access to resources Recommend Favorite

Molecular Pathogenesis of Philadelphia-Positive Chronic Myeloid Leukemia - is it all BCR-ABL?

By  

Current Cancer Drug Targets, Vol. 11, Iss. 1, 2011-01 ,pp. : 3-19

Bentham Science Publishers

Access to resources Recommend Favorite